Magnetar Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$272K Sell
2,465
-1,792
-42% -$173K ﹤0.01% 1090
2026
Q2
$333K Buy
+4,257
New +$290K ﹤0.01% 738
2025
Q4
– Sell
-12,216
Closed -$896K – 1048
2025
Q3
$896K Buy
+12,216
New +$811K 0.01% 480
2022
Q1
– Sell
-5,740
Closed -$231K – 1413
2021
Q4
$231K Sell
5,740
-9,516
-62% -$355K ﹤0.01% 1128
2021
Q3
$621K Buy
+15,256
New +$638K 0.01% 840
2020
Q1
– Sell
-13,422
Closed -$238K – 544
2019
Q4
$238K Buy
+13,422
New +$232K 0.01% 477

Other funds holding HALO

Magnetar Financial's HALO Position: Q3 2026 in Review

Magnetar Financial reduced its Halozyme (HALO) stake by 42% in Q3 2026, selling an estimated $173K and leaving 2,465 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Magnetar Financial first reported a position in HALO in Q4 2019 and has held it in 6 quarters since. The position peaked at $896K in Q3 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Magnetar Financial held 2,465 shares of Halozyme worth $272K as of Q3 2026.
  • Magnetar Financial sold 1,792 Halozyme shares in Q3 2026, an estimated $173K.
  • Halozyme made up ﹤0.01% of Magnetar Financial's portfolio in Q3 2026, its #1090 holding.
  • Magnetar Financial first reported a position in Halozyme in Q4 2019 and has held it in 6 quarters since.
  • Magnetar Financial's Halozyme position peaked at $896K in Q3 2025.
  • 636 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.